FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elliot Barnathan

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Myocardial Infarction

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Stephen I Rennard; Prasheen K Agarwal; Susan K Flavin; Kim Hung Lo; Elliot S Barnathan
Long-term safety study of infliximab in moderate-to-severe chronic obstructive pulmonary disease.
Marc A Judson; Keying Ma; Richard M Marchell; MaryAnn Mascelli; Kevin J Petty; Alexa Piantone; Frédéric Baribaud; Elliot S Barnathan; Dion Chen; Hongtao Fan; Heidi Grund; Carrie Brodmerkel
Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway.
Matthew J Loza; Frédéric Baribaud; Elliot S Barnathan; Rosemary Watt; Stephen I Rennard
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elliot Barnathan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stephen I Rennard; Prasheen K Agarwal; Susan K Flavin; Kim Hung Lo; Elliot S Barnathan
Long-term safety study of infliximab in moderate-to-severe chronic obstructive pulmonary disease.
Respiratory medicine 2013;107(3):424-32.
2012: Marc A Judson; Keying Ma; Richard M Marchell; MaryAnn Mascelli; Kevin J Petty; Alexa Piantone; Frédéric Baribaud; Elliot S Barnathan; Dion Chen; Hongtao Fan; Heidi Grund; Carrie Brodmerkel
Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway.
Journal of the American Academy of Dermatology 2012;66(6):901-10, 910.e1-2.
2012: Matthew J Loza; Frédéric Baribaud; Elliot S Barnathan; Rosemary Watt; Stephen I Rennard
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease.
Respiratory research 2012;13():12.
2011: Matthew J Loza; Carrie Brodmerkel; Roland M Du Bois; Marc A Judson; Ulrich Costabel; Marjolein Drent; mani kavuru; Susan Flavin; Kim Hung Lo; Elliot S Barnathan; Robert P Baughman
Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis.
Clinical and vaccine immunology : CVI 2011;18(6):931-9.
2010: Francesco Prati; Sonia Petronio; Ad J van Boven; Michal Tendera; Leonardo De Luca; Mark A de Belder; Alfredo R Galassi; Fabrizio Imola; Gilles Montalescot; Jan Z Peruga; Elliot S Barnathan; Stephen Ellis; Stefano Savonitto
Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study.
JACC. Cardiovascular interventions 2010;3(12):1284-91.
2010: Gilles Montalescot; Stephen G Ellis; Mark A de Belder; Luc Janssens; Olivier Katz; Wladyslaw Pluta; Patrick Ecollan; Michal Tendera; Ad J van Boven; Petr Widimsky; Henning R Andersen; Amadeo Betriu; Paul Armstrong; Bruce R Brodie; Howard C Herrmann; Franz-Josef Neumann; Mark B Effron; Jiandong Lu; Elliot S Barnathan; Eric J Topol
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).
JACC. Cardiovascular interventions 2010;3(2):203-12.
2009: Howard C Herrmann; Jiandong Lu; Bruce R Brodie; Paul W Armstrong; Gilles Montalescot; Amadeo Betriu; Franz-Joseph Neuman; Mark B Effron; Elliot S Barnathan; Eric J Topol; Stephen G Ellis
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.
JACC. Cardiovascular interventions 2009;2(10):917-24.
2009: Stephen G Ellis; Michal Tendera; Mark A de Belder; Ad J van Boven; Petr Widimsky; Henning R Andersen; Amadeo Betriu; Stefano Savonitto; Jerzy Adamus; Jan Z Peruga; Maciej Hamankiewicz; Waladyslaw Pluta; Keith Oldroyd; Patrick Ecollan; Luc Janssens; Paul Armstrong; Bruce R Brodie; Howard C Herrmann; Gilles Montalescot; Franz-Josef Neumann; Mark B Effron; Elliot S Barnathan; Eric J Topol
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial.
JACC. Cardiovascular interventions 2009;2(10):909-16.
2009: Robert P Baughman; Ralph Shipley; Sujal Desai; Marjolein Drent; Marc A Judson; Ulrich Costabel; Roland M Du Bois; mani kavuru; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Elliot S Barnathan
Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation.
Chest 2009;136(2):526-35.
2009: Sally E Wenzel; Peter J Barnes; Eugene R Bleecker; Jean Bousquet; William Busse; Sven-Erik Dahlén; Stephen T Holgate; Deborah A Meyers; Klaus F Rabe; Adam Antczak; James Baker; Ildiko Horvath; Zsuzsanna Mark; David Bernstein; Edward Kerwin; Rozsa Schlenker-Herceg; Kim Hung Lo; Rosemary Watt; Elliot S Barnathan; Pascal Chanez
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.
American journal of respiratory and critical care medicine 2009;179(7):549-58.
2009: Wolfgang Derer; Elliot S Barnathan; Erdal Safak; Prasheen Agarwal; Harald Heidecke; Martin Möckel; Michael Gross; Cemil Oezcelik; Rainer Dietz; Ralf Dechend
Vitronectin concentrations predict risk in patients undergoing coronary stenting.
Circulation. Cardiovascular interventions 2009;2(1):14-9.
2008: Harold P Adams; Enrique C Leira; James C Torner; Elliot S Barnathan; Lakshmi Padgett; Mark B Effron; Werner Hacke
Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial.
Stroke; a journal of cerebral circulation 2008;39(12):3277-82.
2008: Stephen G Ellis; Michal Tendera; Mark A de Belder; Ad J van Boven; Petr Widimsky; Luc Janssens; H R Andersen; Amadeo Betriu; Stefano Savonitto; Jerzy Adamus; Jan Z Peruga; Maciej Kosmider; Olivier Katz; Thomas Neunteufl; Julia Jorgova; Maria Dorobantu; Liliana Grinfeld; Paul Armstrong; Bruce R Brodie; Howard C Herrmann; Gilles Montalescot; Franz-Josef Neumann; Mark B Effron; Elliot S Barnathan; Eric J Topol
Facilitated PCI in patients with ST-elevation myocardial infarction.
The New England journal of medicine 2008;358(21):2205-17.
2008: Robert P Baughman; Marc A Judson; Alvin Teirstein; Elyse E Lower; Kim Lo; Rozsa Schlenker-Herceg; Elliot S Barnathan
Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems.
American journal of clinical dermatology 2008;9(3):155-61.
2008: Harold P Adams; Mark B Effron; James C Torner; Antoni Dávalos; Judith Frayne; Philip Teal; Jacques Leclerc; Barry Oemar; Lakshmi Padgett; Elliot S Barnathan; Werner Hacke
Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
Stroke; a journal of cerebral circulation 2008;39(1):87-99.
2007: Cynthia M Westerhout; Judy Gnarpe; Wei-Ching Chang; Susan FitzPatrick; Elliot S Barnathan; eric boersma; Robert M Califf; Lars Wallentin; Maarten L Simoons; Paul W Armstrong
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
American heart journal 2007;154(2):306-12.
2007: Stephen I Rennard; Charles Fogarty; Steven Kelsen; William Long; Joe Ramsdell; James Allison; Donald A Mahler; Constantine Saadeh; Thomas Siler; Phillip A. Snell; Phillip Korenblat; William Smith; Mitchell Kaye; Michael Mandel; Charles Andrews; Rachakonda Prabhu; James F Donohue; Rosemary Watt; Kim Hung Lo; Rozsa Schlenker-Herceg; Elliot S Barnathan; John Joseph Murray
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine 2007;175(9):926-34.
2006: Edward M Erin; Brian R Leaker; Grant C Nicholson; Andrew J Tan; Linda M Green; Helen Neighbour; Angela Zacharasiewicz; Jackie Turner; Elliot S Barnathan; Onn Min Kon; Peter J Barnes; Trevor T Hansel
The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.
American journal of respiratory and critical care medicine 2006;174(7):753-62.
2006: Robert P Baughman; Marjolein Drent; mani kavuru; Marc A Judson; Ulrich Costabel; Roland M Du Bois; Carlo Albera; Martin H Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
American journal of respiratory and critical care medicine 2006;174(7):795-802.
2005: Wei-Ching Chang; William K Midodzi; Cynthia M Westerhout; eric boersma; Judith Cooper; Elliot S Barnathan; Maarten L Simoons; Lars Wallentin; Erik Ohman; Paul W Armstrong
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.
Journal of epidemiology and community health 2005;59(5):427-33.
2004: Mary Ann Mascelli; Efthymios Deliargyris; Lakshmi V Damaraju; Elliot S Barnathan; Robert M Califf; Maarten L Simoons; David C Sane
Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromes.
Journal of thrombosis and thrombolysis 2004;18(3):171-5.
2004: Jan Paul Ottervanger; Paul Armstrong; Elliot S Barnathan; eric boersma; J S Cooper; Erik Ohman; Stefan James; Lars Wallentin; Maarten L Simoons
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS.
European heart journal 2004;25(17):1494-501.
2004: Mary Ann Mascelli; Efthymios Deliargyris; Lakshmi V Damaraju; Elliot S Barnathan; David C Sane
Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromes.
Seminars in thrombosis and hemostasis 2004;30(3):347-50.
2004: Jean-Pierre Dery; Gregory A Braden; A Michael Lincoff; Dean J Kereiakes; Kevin Browne; Thomas Little; Barry S George; David C Sane; Douglas B Cines; Mark B Effron; Mary Ann Mascelli; Mary Ann Langrall; Lakshmi V Damaraju; Elliot S Barnathan; James E Tcheng
Final results of the ReoPro readministration registry.
The American journal of cardiology 2004;93(8):979-84.
2004: Marian T Nakada; Michael O Montgomery; Mark A Nedelman; J Luis Guerrero; Sidney A Cohen; Elliot S Barnathan; Robert E Jordan
Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.
Journal of vascular and interventional radiology : JVIR 2004;15(2 Pt 1):169-76.
2004: Stefan K James; Agneta Siegbahn; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Maarten L Simoons; Lars Wallentin
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.
American heart journal 2004;147(2):267-74.
2003: Stefan K James; Bertil Lindahl; Agneta Siegbahn; Mats Stridsberg; Per Venge; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Eric J Topol; Maarten L Simoons; Lars Wallentin
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
Circulation 2003;108(3):275-81.
2003: R Taylor Williams; Lakshmi V Damaraju; Mary Ann Mascelli; Elliot S Barnathan; Robert M Califf; Maarten L Simoons; Efthymios Deliargyris; David C Sane
Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.
Circulation 2003;107(18):2307-12.
2003: Stefan K James; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Bertil Lindahl; Agneta Siegbahn; Maarten L Simoons; Eric J Topol; Per Venge; Lars Wallentin
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2003;41(6):916-24.
2003: Jan Paul Ottervanger; Paul Armstrong; Elliot S Barnathan; eric boersma; J S Cooper; Erik Ohman; Stefan James; Eric J Topol; Lars Wallentin; Maarten L Simoons
Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.
Circulation 2003;107(3):437-42.
2003: C L Wagner; A Schantz; Elliot S Barnathan; A Olson; Mary Ann Mascelli; J Ford; Lakshmi V Damaraju; Thomas Schaible; R N Maini; J E Tcheng
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.
Developments in biologicals 2003;112():37-53.
2002: Jane Freedman; Mary Ann Mascelli; John C Pezzullo; Elliot S Barnathan; Bart Frederick; Robert E Jordan; Darrell R. Abernethy
Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects.
American heart journal 2002;143(1):87-94.
2001: A Michael Lincoff; Dean J Kereiakes; Mary Ann Mascelli; L I Deckelbaum; Elliot S Barnathan; K K Patel; Bart Frederick; Marian T Nakada; Eric J Topol
Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.
Circulation 2001;104(2):163-7.
2000: SA Coulter; Christopher P Cannon; K A Ault; Elliott M Antman; Frans Van de Werf; A A Jennifer Adgey; C Michael Gibson; Robert P Giugliano; Mary Ann Mascelli; J Scherer; Elliot S Barnathan; Eugene Braunwald; N S Kleiman
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.
Circulation 2000;101(23):2690-5.
2000: M Molino; Marilyn J Woolkalis; Nicolas Prévost; D Praticó; Elliot S Barnathan; G Taraboletti; Beth Haggarty; Joseph Hesselgesser; Richard Horuk; James A Hoxie; Lawrence F Brass
CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2.
Biochimica et biophysica acta 2000;1500(2):227-40.
1999: Katalin Karikó; Alice Kuo; Elliot S Barnathan
Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA.
Gene therapy 1999;6(6):1092-100.
1998: A W Chang; Alice Kuo; Elliot S Barnathan; S S Okada
Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(12):1855-60.
1998: S S Okada; Michael A Golden; Puthiyaveettil N Raghunath; John E Tomaszewski; M L David; Alice Kuo; Katalin Kariko; Elliot S Barnathan
Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo.
Thrombosis and haemostasis 1998;80(1):140-7.
1998: Douglas B Cines; Eleanor S Pollak; C A Buck; J Loscalzo; G A Zimmerman; R P McEver; J S Pober; T M Wick; Barbara A Konkle; Bradford S. Schwartz; Elliot S Barnathan; K R McCrae; Bruce A Hug; Ann Marie Schmidt; David M Stern
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Blood 1998;91(10):3527-61.
1998: M Molino; Puthiyaveettil N Raghunath; Alice Kuo; M Ahuja; James A Hoxie; Lawrence F Brass; Elliot S Barnathan
Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(5):825-32.
1998: Katalin Karikó; Alice Kuo; Elliot S Barnathan; David Langer
Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA.
Biochimica et biophysica acta 1998;1369(2):320-34.
1998: Terence W McGarvey; Katalin Kariko; Elliot S Barnathan; J Thomas; S Bruce Malkowicz
The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
International journal of oncology 1998;12(1):175-80.
1998: David G Neschis; Shawn D Safford; Puthiyaveettil N Raghunath; David Langer; M L David; AK Hanna; John E Tomaszewski; Katalin Kariko; Elliot S Barnathan; Michael A Golden
Thermal preconditioning before rat arterial balloon injury: limitation of injury and sustained reduction of intimal thickening.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(1):120-6.
1997: David DeNofrio; Elliot S Barnathan; Evan Loh
Images in cardiovascular medicine. Left anterior descending coronary artery-to-right ventricle fistula.
Circulation 1997;96(10):3779.
1997: Paul B Weisz; Madeleine M Joullié; C M Hunter; K M Kumor; Z Zhang; E Levine; Edward J Macarak; David Weiner; Elliot S Barnathan
A basic compositional requirement of agents having heparin-like cell-modulating activities.
Biochemical pharmacology 1997;54(1):149-57.
1997: M Molino; Marilyn J Woolkalis; J Reavey-Cantwell; D Praticó; P Andrade-Gordon; Elliot S Barnathan; Lawrence F Brass
Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment.
The Journal of biological chemistry 1997;272(17):11133-41.
1997: Elliot S Barnathan; Puthiyaveettil N Raghunath; John E Tomaszewski; T Ganz; Douglas B Cines
Immunohistochemical localization of defensin in human coronary vessels.
The American journal of pathology 1997;150(3):1009-20.
1997: M Molino; Elliot S Barnathan; R Numerof; J Clark; M Dreyer; A Cumashi; James A Hoxie; Norman M Schechter; Marilyn J Woolkalis; Lawrence F Brass
Interactions of mast cell tryptase with thrombin receptors and PAR-2.
The Journal of biological chemistry 1997;272(7):4043-9.
1996: Vladimir R Muzykantov; Elliot S Barnathan; Elena N Atochina; Alice Kuo; Sergei M Danilov; Aron B Fisher
Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature.
The Journal of pharmacology and experimental therapeutics 1996;279(2):1026-34.
1996: Abd Al-Roof Higazi; D Kniss; J Manuppello; Elliot S Barnathan; Douglas B Cines
Thermotaxis of human trophoblastic cells.
Placenta 1996;17(8):683-7.
1996: S S Okada; S R Grobmyer; Elliot S Barnathan
Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(10):1269-76.
1996: Vladimir R Muzykantov; Elena N Atochina; Alice Kuo; Elliot S Barnathan; K Notarfrancesco; Henry Shuman; Chandra Dodia; Aron B Fisher
Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme.
The American journal of physiology 1996;270(5 Pt 1):L704-13.
1996: G J Toes; Elliot S Barnathan; H Liu; Puthiyaveettil N Raghunath; John E Tomaszewski; R J Caron; P B Weisz; Wim van Oeveren; Michael A Golden
Inhibition of vein graft intimal and medial thickening by periadventitial application of a sulfated carbohydrate polymer.
Journal of vascular surgery 1996;23(4):650-6.
1995: W B Bachinsky; Elliot S Barnathan; H Liu; S S Okada; Alice Kuo; Puthiyaveettil N Raghunath; M Muttreja; R J Caron; John E Tomaszewski; Michael A Golden
Sustained inhibition of intimal thickening. In vitro and in vivo effects of polymeric beta-cyclodextrin sulfate.
The Journal of clinical investigation 1995;96(6):2583-92.
1995: H W Schnaper; Elliot S Barnathan; Andrew P Mazar; S Maheshwari; S Ellis; S L Cortez; William H Baricos; Hynda K Kleinman
Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
Journal of cellular physiology 1995;165(1):107-18.
1995: Puthiyaveettil N Raghunath; John E Tomaszewski; S T Brady; R J Caron; S S Okada; Elliot S Barnathan
Plasminogen activator system in human coronary atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(9):1432-43.
1995: S S Okada; Alice Kuo; M R Muttreja; E Hozakowska; P B Weisz; Elliot S Barnathan
Inhibition of human vascular smooth muscle cell migration and proliferation by beta-cyclodextrin tetradecasulfate.
The Journal of pharmacology and experimental therapeutics 1995;273(2):948-54.
1995: Vladimir R Muzykantov; V D Gavriluk; A Reinecke; Elena N Atochina; Alice Kuo; Elliot S Barnathan; Aron B Fisher
The functional effects of biotinylation of anti-angiotensin-converting enzyme monoclonal antibody in terms of targeting in vivo.
Analytical biochemistry 1995;226(2):279-87.
1995: Katalin Karikó; H Rosenbaum; Alice Kuo; Robert B Zurier; Elliot S Barnathan
Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor-1 mRNA in cultured human endothelial cells.
FEBS letters 1995;361(1):118-22.
1995: S S Okada; John E Tomaszewski; Elliot S Barnathan
Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro.
Experimental cell research 1995;217(1):180-7.
1994: W B Bachinsky; Elliot S Barnathan
Angioplasty in multivessel coronary artery disease.
Hospital practice (Office ed.) 1994;29(12):27-33.
1994: Katalin Karikó; K Megyeri; Q Xiao; Elliot S Barnathan
Lipofectin-aided cell delivery of ribozyme targeted to human urokinase receptor mRNA.
FEBS letters 1994;352(1):41-4.
1994: F Li; Elliot S Barnathan; Katalin Karikó
Rapid method for screening and cloning cDNAs generated in differential mRNA display: application of northern blot for affinity capturing of cDNAs.
Nucleic acids research 1994;22(9):1764-5.
1994: Hui Li; Alice Kuo; J Kochan; Dudley K Strickland; Katalin Kariko; Elliot S Barnathan; Douglas B Cines
Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
The Journal of biological chemistry 1994;269(11):8153-8.
1993: PT Vaitkus; Elliot S Barnathan
Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis.
Journal of the American College of Cardiology 1993;22(4):1004-9.
1993: Katalin Karikó; Alice Kuo; D Boyd; S S Okada; Douglas B Cines; Elliot S Barnathan
Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.
Cancer research 1993;53(13):3109-17.
1993: S R Grobmyer; Alice Kuo; M Orishimo; S S Okada; Douglas B Cines; Elliot S Barnathan
Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells.
The Journal of biological chemistry 1993;268(18):13291-300.
1993: H C Herrmann; S S Okada; E Hozakowska; R F LeVeen; Michael A Golden; John E Tomaszewski; P B Weisz; Elliot S Barnathan
Inhibition of smooth muscle cell proliferation and experimental angioplasty restenosis by beta-cyclodextrin tetradecasulfate.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(6):924-31.
1993: W G Kussmaul; J Krol; K Marzo; PT Vaitkus; William H Matthai; S Brady; A Rosenthal; Elliot S Barnathan; M N Walsh
A randomized controlled trial of the efficacy, safety and cost of a single-use myocardial bioptome.
The Journal of invasive cardiology 1993;5(4):148-52.
1992: W Hollas; N Hoosein; Leland W K Chung; Andrew P Mazar; Jack Henkin; Katalin Kariko; Elliot S Barnathan; D Boyd
Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines.
Thrombosis and haemostasis 1992;68(6):662-6.
1992: PT Vaitkus; Jesse A Berlin; J Sanford Schwartz; Elliot S Barnathan
Stroke complicating acute myocardial infarction. A meta-analysis of risk modification by anticoagulation and thrombolytic therapy.
Archives of internal medicine 1992;152(10):2020-4.
1992: L Rosenfeld; Alice Kuo; J Hirsh; B Klugherz; S J Gardell; Douglas B Cines; Elliot S Barnathan
Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells.
Blood 1992;80(6):1486-95.
1992: J M Zini; S C Murray; Charles H Graham; P K Lala; Katalin Karikó; Elliot S Barnathan; Andrew P Mazar; Jack Henkin; Douglas B Cines; Keith R McCrae
Characterization of urokinase receptor expression by human placental trophoblasts.
Blood 1992;79(11):2917-29.
1991: G R Larsen; Elliot S Barnathan
Thrombolytic therapy with tissue-type plasminogen activator: new modes and novel variant plasminogen activators.
Current opinion in biotechnology 1991;2(2):220-6.
1990: Elliot S Barnathan; Alice Kuo; Katalin Karikó; L Rosenfeld; S C Murray; Niels Behrendt; E Rønne; David Weiner; Jack Henkin; Douglas B Cines
Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA.
Blood 1990;76(9):1795-806.
1990: M A Laskey; E Deutsch; Elliot S Barnathan; Warren K Laskey
Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectoris.
The American journal of cardiology 1990;65(22):1425-9.
1990: Elliot S Barnathan; Alice Kuo; L Rosenfeld; Katalin Karikó; M Leski; F Robbiati; M L Nolli; Jack Henkin; Douglas B Cines
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
The Journal of biological chemistry 1990;265(5):2865-72.
1990: M A Laskey; E Deutsch; John W Hirshfeld; W G Kussmaul; Elliot S Barnathan; Warren K Laskey
Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus.
The American journal of cardiology 1990;65(3):179-82.
1988: Elliot S Barnathan; Alice Kuo; H Van der Keyl; Keith R McCrae; G R Larsen; Douglas B Cines
Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites.
The Journal of biological chemistry 1988;263(16):7792-9.
1988: Elliot S Barnathan; J W Hirshfeld
Adjunctive pharmacologic treatment.
Cardiovascular clinics 1988;19(2):41-78.
1987: Elliot S Barnathan; J S Schwartz; L Taylor; Warren K Laskey; J P Kleaveland; W G Kussmaul; John W Hirshfeld
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
Circulation 1987;76(1):125-34.